Provided by Tiger Trade Technology Pte. Ltd.

Ocugen

1.00
-0.0400-3.85%
Volume:4.64M
Turnover:4.74M
Market Cap:338.52M
PE:-3.92
High:1.05
Open:1.04
Low:1.00
Close:1.04
52wk High:2.73
52wk Low:0.9700
Shares:338.52M
Float Shares:327.56M
Volume Ratio:0.91
T/O Rate:1.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2551
EPS(LYR):-0.2260
ROE:-660.00%
ROA:-48.44%
PB:-20.45
PE(LYR):-4.42

Loading ...

Ocugen Names Jolanda Crombach General Manager of European Affiliate

Reuters
·
Oct 06

Ocugen Appoints Industry Executive Jolanda Crombach General Manager of European Affiliate

THOMSON REUTERS
·
Oct 06

Ocugen Reconvenes Special Shareholder Meeting, Adjourns Vote on Authorized Share Increase Proposal

Reuters
·
Oct 06

Ocugen Inc. Stock Rises Monday, Outperforms Market

Dow Jones
·
Oct 06

Ocugen Inc. Stock Rises Friday, Outperforms Market

Dow Jones
·
Oct 03

Ocugen Inc. Stock Falls Thursday, Underperforms Market

Dow Jones
·
Oct 02

Ocugen Inc. Stock Sheds 5.5%, Underperforms Market

Dow Jones
·
Oct 01

Analyst Maintains Buy Rating on Ocugen as OCU400’s Early Revenue Pathway and Phase 3 Upside Support Unchanged $11 Price Target

TIPRANKS
·
Sep 30

Ocugen to Present 12-Month Phase 2 ArMaDa Trial Results for Ocu410 Gene Therapy in Geographic Atrophy at AAO 2026

Reuters
·
Sep 30

Ocugen to Participate in Upcoming Scientific Conferences

GlobeNewswire
·
Sep 30

Ocugen Inc. Stock Rallies 5.8%, Outperforms Market

Dow Jones
·
Sep 30

Ocugen CEO Musunuri Moderates H.C. Wainwright Biotech on Tap Panel

Reuters
·
Sep 29

AstraZeneca To Invest $2 Billion In Summit And Co-Develop Drugs; Shares Jump After Hours

Options & Short Sell
·
Sep 29

Ocugen Inc. Stock Rises Friday, Outperforms Market

Dow Jones
·
Sep 26

Ocugen Shares Rise on Provisional Approval for Retinitis Pigmentosa Treatment in Bahamas

Dow Jones
·
Sep 25

Ocugen Wins Provisional Approval for Ocu400 in Bahamas Under LARTA Pathway

Reuters
·
Sep 25

Ocugen Receives Provisional Approval and Priority Designation Under the Longevity and Regenerative Therapies Act in the Bahamas to Provide Ocu400 to Patients for Treatment of Retinitis Pigmentosa

THOMSON REUTERS
·
Sep 25

Ocugen Inc. Stock Slips 3.8%, Underperforms Market

Dow Jones
·
Sep 24

Ocugen Stockholders Meeting Draws Quorum with 160,214,431 Shares Represented

Reuters
·
Sep 23

Ocugen Inc. Stock Falls Monday, Underperforms Market

Dow Jones
·
Sep 22